The first Directive focusing on ‘Patients’ Rights’ – what does this really mean for patients? „Start by doing what's necessary then do what's possible.

Slides:



Advertisements
Similar presentations
S.O.S. eHealth Project Open eHealth initiative for a European large scale pilot of patient summary and electronic prescription Daniel Forslund, Head of.
Advertisements

Directive on patients rights in cross-border healthcare DG SANCO Unit D2 Healthcare systems.
This project is funded by the EUAnd implemented by a consortium led by MWH Amman – 23 April 2012 RCBI ‘handover’ meeting Jordan.
Health & Consumer Protection Directorate General The EU Health Strategy and the new Health and Consumer Protection Programme Bernard Merkel Paula.
EU Cross-Border Care Directive from the Primary Care perspective Results of a simulation Rita Baeten Gothenburg, 3 September 2012.
AVOID A CHRONIC PAIN AS A PATIENTS’ RIGHT Teresa Petrangolini Active Citizenship Network - PAE.
Association for the Education of Adults EAEA European AE Research – Look towards the future ERDI General Assembly, 2004.
Dorota Kilańska RN, PhD European Nursing Research Foundation (ENRF)
1 IPSG WORKSHOP 1 - CHALLENGES AND TOOLS FOR THE CENTRE OF GOVERNMENT There is an observable trend towards direction of centralization of the CoG: Reasons.
DIRECTIVE OF THE EUROPEAN PARLIAMENT AND THE COUNCIL on the application of patients' rights in CROSS-BORDER HEALTHCARE voted Karleen De Rijcke.
Cross-border healthcare The Belgian experience Conference of the National Health Fund, Warsaw - 18/06/2015 Christian Horemans Expert International Affairs.
The involvement of patients in Health Technology Assessment Andrzej Rys Director Health and Consumers Directorate-General Brussels 18 May 2010.
Criteria for Centres of Expertise for Rare Diseases in the EU following EUCERD Recommendations RARECARENet Project: Consensus meeting on.
Directive on the application of patients’ rights in cross-border healthcare Recent developments Jooske Vos European Partnership for Supervisory Organisations.
Cross-border healthcare Directive: latest news John Rowan First Secretary (Health and Pharmaceuticals), Permanent Representation of the United Kingdom.
Development and application of guidance documents – industry view Dr Martin Schaefer ECCA-ECPA Conference March 2014.
The European Network for Patient Safety & Quality JA PaSQ International Forum on Quality & Safety in Healthcare Paris, 10 April 2014 J.Bacou, HAS PaSQ.
A major step towards a Europe for Health Directive on patients’ rights in cross-border healthcare DG SANCO D2 Healthcare Systems.
A major step towards a Europe for Health Directive on patients’ rights in cross-border healthcare DG SANCO Unit D2 Healthcare systems.
Directive Patient mobility Brigitte van der Zanden Taskforce Health AEBR 12 November 2009 Brussels - AER.
European Commission Introduction to the Community Programme for Employment and Social Solidarity PROGRESS
Leonardo da Vinci Partnerships: an opportunity to work together Italian National Agency for LLP - Leonardo da Vinci Sectoral Programme.
Patient’s Bill of Rights. The pt. has the right to considerate and respectful care. The pt. has the right to considerate and respectful care. The pt.
PRISON HEALTH IN EUROPE: MISSIONS, ROLES AND RESPONSIBILITIES OF INTERNATIONAL ORGANIZATIONS Strasbourg, France 27 th May 2014.
Health Promotion as a Quality issue
Orphanet Europe State of the Art of Database and Services Polish activity Orphanet Europe State of the Art of Database and Services Polish.
Health challenges in an enlarged Europe Report from Parallel Session A1 Dr. Natasha Azzopardi Muscat Ministry of Health - Malta.
EUNetPaS is a project supported by a grant from the EAHC. The sole responsibility for the content of this presentation lies with the author(s). The EAHC.
Community action on cross-border healthcare Royal College of Physicians 17 January 2008 Robert Madelin Director General for health and consumer protection.
2009/10/06 STUDY ON RECOGNITION OF PROFESSIONAL QUALIFICATIONS Alternative title slide.
HTA Benefits and Risks Dr Bernard Merkel European Commission.
EARIP Stakeholder Workshop Models and healthcare systems: transferability of best practice across Europe Dr. Aurélien PEREZ European Commission Health.
MEDICAL SERVICE ADMINISTRATION VIETNAM MINISTRY OF HEALTH
HEALTH FINANCING MOH - HPG JAHR UPDATE ON POLICIES Eleventh Party Congress -Increase state investment while simultaneously mobilizing social mobilization.
EPHA Briefing Paper (Part 2): High Level Reflection Process on Patient Mobility in the EU - summary of final recommendations - December 2003 (See also.
EUNetPaS is a project supported by a grant from the EAHC. The sole responsibility for the content of this presentation lies with the author(s). The EAHC.
Mt. Hood. IOM Report: 10 Years After & More Coming Mitch Greenlick, Ph.D. Oregon State Representative April 21, 2010.
Impact analysis during the harmonisation process with the EU and effects on Lithuanian economy Giedrius Kadziauskas, Senior Policy analyst 23 rd Fabruary.
1st eHealth conference - Sofia01/02/2006 The Added Value of eHealth by Marc Lange.
European Health Forum Gastein Workshop International Quality Comparisons 6 October 2005 "Measuring the patient's perspective: Current and future work in.
Health Technology Assessment Methodology, an EUnetHTA View Basics for the Assessment in EU Countries PharmDr. Martin Visnansky, MBA, PhD., MSc. (HTA) HTA.
Week 12. Lecture 2. Health Law & the EU Cross-border healthcare: patients’ rights.
A look into current and future trends in national policies for eHealth and Innovation in the WHO European Region Clayton Hamilton, eHealth and Innovation.
The legal aspects of eHealth: the specific case of telemedicine Céline Deswarte ICT for Health Unit, European Commission TAIEX Multi-country seminar on.
European network for Health Technology Assessment | JA | EUnetHTA European network for Health Technology Assessment THL Info.
Hearing on Cross-border healthcare system Tunde Koltai Hungarian Alliance of Patient Organizations 29 February 2016.
Cross border Patients’ rights Claire Damilano, Senior Legal Manager European Citizen Action Service U-Impact debate in Rome – 4 March /03/2016U-impact1.
M O N T E N E G R O Negotiating Team for the Accession of Montenegro to the European Union Working Group for Chapter 28 – Consumer and Health Protection.
The continuum of care: The Role of Technology
Anne-Marie Yazbeck, PhD National Infoday, Sweden 2017
A capacity building programme for patient representatives
Disclosure UK Talking about Transparency.
Is medical revalidation building trust and assurance in doctors
Health Technology Assessment
Cross-border healthcare and the EU Directive 24/2011
Dorota Kilańska RN, PhD European Nursing Research Foundation (ENRF)
RIA: Communication – building credibility
Musculoskeletal Health in Europe
Disclosure UK Talking about Transparency.
Statutory participatory mechanisms
Dan Tofan | Expert in NIS 21st Art. 13a WG| LISBON |
Commission report on the operation of the Directive 2011/24 on the application of patients’ rights in cross-border healthcare Health and Food Safety Directorate.
Mapping Educational Paths of Youth Workers and Gathering Knowledge on Youth Work Expert Group meeting – 31 May 2018.
Need for a strong Commission for healthcare
CPME Activities UEMS Council meeting Dr Jacques de HALLER
Raising the bar Meeting Europe’s future challenges
Directive 2011/24/EU on patients’ rights in cross-border healthcare
STRUCTURE AND METHODS OF CO-OPERATION
Comprehensive M&E Systems
Arthritis and Musculoskeletal Alliance
Presentation transcript:

The first Directive focusing on ‘Patients’ Rights’ – what does this really mean for patients? „Start by doing what's necessary then do what's possible and suddenly you are doing the impossible” Saint Francis of Assisi Pogány Gábor Ph.D. Coordinator of Hungarian Patients Forum, President of HUFERDIS Member of Orphanet International Advisory Board http://nemzetibetegforum.hu/, www.rirosz.hu, www.eurordis.org, www.orpha.net ACN webinar: towards a European Patients Centre Network, 04.03.2016

The 3 aims of the Directive Help patients to exercise their rights to reimbursement for healthcare received in another EU country Provide assurance about safety and quality of cross-border healthcare Establish formal cooperation between health systems

Helping patients Information to patients Rules of reimbursement Patients will have to access to all relevant information via National Contact Points Rules of reimbursement Clarification of rules – patients will know: a, need for prior authorisation; b, reasons for refusal; c, level of reimbursement, and d, need for up-front payment Procedural guarantees Patients will benefit from: a, clarification of responsibilities; b, clear rules if something goes wrong; c, right to review of administrative decisions; d, right to judicial proceedings

Rare disease patients Easier access to information The National Contact Points will make patients, health professionals and payers of healthcare aware of the possibilities for referral to other MS-s Dissemination of expertise By means of e-Health tools, databases (Orphanet, etc.) and networking of Centres of Expertise Fostering appropriate clinical assessment Decisions about prior authorisation (for diagnosis especially) should be based on appropriate clinical evaluation by experts in that field

Quality and safety Transparency and accountability Information on healthcare providers and on standards applied Member States responsibility Refusal of prior authorisation if doubts over quality and safety of healthcare provider Cooperation of Member States On standards and guidelines on quality and safety

Cooperation between health systems Recognition of prescriptions A prescription issued in another country will be more effectively recognised European Reference Networks They will bring together specialised centres across Europe helping health experts to disseminate information and expertise Health Technology Assessment A permanent EU structure of cooperation to help decision-makers to make the right decisions on health investment and spending E-Health A first step towards „interoperability” of ICT for health at EU level for safety and quality of care, continuity of care, and health research

We have both the Regulation and the Directive! Prior authorisation not needed if treatment is on the « list » When on the list, reimbursement on the basis of their cost in country of affiliation It is possible that patients would find it better to apply for cross border health care under the Regulation than under the new Directive!

Questions to NCP 14% rights by the Directive 24% rights by the Regulation 1% other NCPs 9% cross-border healthcare services 4% pre-authorization 4% reimbursement procedures 3% HC providers 5% HC services 1% quality and safety 1% prices 3% equity 3% healthcare collaboration 3% complaints 5% general operational questions 21% local and EU healthcare information Source: OBDK

Statistical DATA Hungarians to Abroad Period: 25.10.2013 – 31.03.2015 Requests arrived 665 Pre-authorisation needed 662 Without pre-authorisation 3 Authorized 491 Refused 67 Simply not-authorized 62 Process cancelled 45 Source: OBDK

Statistical data 2014 from abroad to Hungary Total: 2519 persons Outpatient care 74% „Wellness” 1% RO 843 SI 217 HU 183 GB 180 Others 437 CT 3% Dental care 2% RO 292 HU 95 IT 26 GB 19 Others 62 Hospital care 20% Source: OBDK

Survey of Hungarian Patient Organizations Bureaucratic and too long decision making! Patient needs to prepay, than a reimbursement is possible. Lack of reaching out to society

Facts The patients are NOT going abroad because: The ‚bigger’ treatments are subject of prior authorisation The ‚smaller’ treatments and/or medicaments and/or medical devices will not be reimbursed (below the limit) Extremely high costs of the ‚official translation’ – even higher than the reimbursed amount The reimbursed amount is below the real costs which was invoiced and pre-paid to the healthcare provider because of the local „list-prices” of the NHS The healthcare providers are NOT interested in CBHC because: They can not invoice the real costs of the interventions – unless the patients’ budget would allow it – because they have a ‚price-list’ of NHS and these prices are not reflecting the real costs Some countries’ patients could not be authorised to treated abroad

What is the impact for the EU? For every patient treated earlier, a gain in EU-wide healthcare efficiency, AND of EU-wide well-being Patient-mobility remains limited (currently 1%); but impact for individual patients is high No significant impact on national budgets. Quality and safety of cross-border care improves More clarity for all about rules for reimbursement of care Patients have better access to the care they need

What patient organizations can do? Get informed about the content and the implications of the Directive Can raise awareness and help patients find the right information Propose concrete measures of interest to patients Insist on NCP involves the patient organizations as regular partners Create guidelines for information to patients Feed back experiences to decision makers Participate in the ACN supposed EPC-Net 

Respond to questions 1. Based on your experience, what are the main challenges or concerns in your country for patients willing to travel abroad for care? Have you got any data or significant case history you would like to share? The health status of the citizens – one of the worst in the EU The healthcare professionals (HCPs) are underpaid The HCPs leave the country + e.g. the family doctors’ are +60

Respond to questions 2. What should be done at EU level because the transposition process would not only be a “problem” of single Member States but a coordinated action supervised by the EU institutions? elaborate/harmonising quality and safety rules and indicators role of NCPs: instead of „gatekeeper” „infocenter” +patient support clear distinction between healthcare services under the directive and regulation and border-regions co-operation

Respond to questions 3. What can we DO and PROPOSE as a group of different stakeholders for a more effective implementation? Involve patient organisations (PO) to harmonising the quality and safety rules Involve POs to dissemination of CBHC directive Continuous training for PO leaders/team leaders – update their knowledge and info materials about CBHC

Thank you for your attention! www.nemzetibetegforum.hu, www.rirosz.hu, www.eurordis.org Rare Diseases Hungary e-mail: pogany.gabor@nemzetibetegforum.hu Cím: 1051 Budapest, Arany János u. 6-8. Tel: (36-1) 326-7492, Fax: (36-1) 438-0739